Short Term Trade Idea Buy (CIPLA)

30 Kas 2022

Health Care
Pharmaceuticals

Largecap
With a market cap of ₹88,870 cr, stock is ranked 60

Stock has been generating better return on equity than bank FD

Stock doesn't offer attractive dividend returns

Good time to consider, as stock is not in overbought zone

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged



Disclaimer : I am not a SEBI Registered Research Analyst so before your Investment Please Consult you Financial adviser.